Eurofins Scientific Acquires 30,000 Own Shares on the Market
Eurofins Scientific acquired 30,000 own shares between January 12 and January 16, 2026 on Euronext Paris, according to a statement released this Monday. The weighted average price was set at 71.91 euros per share.
According to the group, the repurchases were spread over five consecutive trading sessions. On January 12, 10,000 shares were acquired at an average price of 70.5975 euros. In the following days, 5,000 shares were repurchased daily, at average prices of 72.9633 euros on January 13, 72.6177 euros on January 14, 72.2203 euros on January 15, and 72.4636 euros on January 16. All transactions were carried out on the regulated market Euronext Paris, identified by the code XPAR. The statement specifies that these operations involve the financial instrument FR0014000MR3, corresponding to the company's ordinary shares.
Context of the Share Buyback
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
Almost there! Check your inbox.
A confirmation email has been sent. Click the link to confirm your subscription.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
These share repurchases are part of the company's own share buyback program, the company indicates. In accordance with Article 5, paragraph 1, point b, of European Regulation number 596/2014 on market abuse, Eurofins Scientific publishes the full details of the individual transactions on its investor website. The issuer identifier code used in the declaration is 529900JEHFM47DYY3S57.
Nous sommes satisfaits d’avoir atteint nos objectifs 2025 et de démontrer la solidité du portfolio Eurofins.
La performance 2025 est soutenue par la croissance organique et l’expansion des marges, avec un flux de trésorerie libre robuste et un endettement maîtrisé.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
